Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Herbicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Atrazine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00969
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Herbicide |
DME Modulation |
Atrazine up-regulates the expression of DME GFPT2 |
[1] |
Health or Environmental Toxicant(s) |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene up-regulates the expression of DME GFPT2 |
[2] |
Aflatoxin B1 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00806
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen-mycotoxin |
DME Modulation |
Aflatoxin B1 up-regulates the expression of DME GFPT2 |
[3] |
Health Hazard/Toxicant |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
1-methyl-4-phenylpyridinium |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01103
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
1-methyl-4-phenylpyridinium up-regulates the expression of DME GFPT2 |
[4] |
Butyraldehyde |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00999
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Health Hazard |
DME Modulation |
Butyraldehyde up-regulates the expression of DME GFPT2 |
[5] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 6 Xenobiotics
|
Calcitriol |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00184
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Calcitriol inhibits the expression of DME GFPT2 |
[6] |
Cisplatin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cisplatin inhibits the expression of DME GFPT2 |
[7] |
Doxorubicin hydrochloride |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00292
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Doxorubicin hydrochloride inhibits the expression of DME GFPT2 |
[8] |
Progesterone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00094
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Progesterone induces the drug-metabolizing activity of DME GFPT2 |
[9] |
Tretinoin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00253
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Tretinoin up-regulates the expression of DME GFPT2 |
[10] |
Urethane |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00435
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Urethane up-regulates the expression of DME GFPT2 |
[11] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
MS-275 |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00581
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
MS-275 up-regulates the expression of DME GFPT2 |
[12] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Sodium arsenite |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00632
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Sodium arsenite up-regulates the expression of DME GFPT2 |
[13] |
Trichostatin A |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01492
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Trichostatin A up-regulates the expression of DME GFPT2 |
[14] |
|
|
|
|
|
|